abs408.txt	background		oncolytic	viruses	are	genetically	engineered	or	naturally	occurringviruses	that	selectively	replicate	in	cancer	cells	without	harming	normal	talimogene	laherparepvec	(imlygicÂ®)	the	first	viral	therapy	approvedfor	treatment	of	was	approved	for	locally	advanced	melanomain	october	2015	purpose	as	a	biologic	product	use	t	clinical	settingrequires	pretreatment	planning	and	unique	systematic	approach	to	deliver	thetherapy	processes	we	describe	herein	could	be	adopted	by	other	centers	thatchoose	prescribe	methods	studied	our	trial	experience	with	before	weembarked	on	using	commercially	available	created	standardoperating	procedure	(sop)	multidisciplinary	buy-in	oversight	fromleadership	infection	control	at	institution	reflected	clinicalcases	actual	procedures	administering	create	thesop	results	preimplementation	patient	selection	identification	oflesions	treat	ongoing	assessment	patients	aredescribed	tumoral-related	factors	lead	challenges	described	conclusions	process	ensure	safe	responsible	implementation	programto	administer	melanoma	may	improve	qualityof	who	suffer	from
